Susquehanna Fundamental Investments’s Oric Pharmaceuticals ORIC Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,518	Closed	-$209K	–	640
2025 Q4	$209K	Hold	25,518	–	–	0.01%	509
2025 Q3	$306K	Sell	25,518 -17,875	-41%	-$188K	0.01%	479
2025 Q2	$440K	Sell	43,393 -25,643	-37%	-$172K	0.01%	572
2025 Q1	$385K	Buy	69,036 +48,761	+240%	+$426K	0.01%	902
2024 Q4	$164K	Buy	+20,275	New	+$186K	﹤0.01%	1021
2022 Q1	$73K	Sell	13,643 -12,900	-49%	-$116K	﹤0.01%	1476
2021 Q4	$390K	Buy	26,543 +5,144	+24%	+$80.2K	0.01%	1018
2021 Q3	$447K	Buy	+21,399	New	+$434K	0.01%	1259

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Susquehanna Fundamental Investments's ORIC Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of Oric Pharmaceuticals (ORIC) in Q1 2026, closing a stake of 25,518 shares — an estimated $209K sold.

Susquehanna Fundamental Investments first reported a position in ORIC in Q3 2021 and held it in 8 quarters. The position peaked at $447K in Q3 2021. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

Susquehanna Fundamental Investments reported no remaining Oric Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Susquehanna Fundamental Investments sold 25,518 Oric Pharmaceuticals shares in Q1 2026, an estimated $209K.
Susquehanna Fundamental Investments first reported a position in Oric Pharmaceuticals in Q3 2021 and held it in 8 quarters.
Susquehanna Fundamental Investments's Oric Pharmaceuticals position peaked at $447K in Q3 2021.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.